http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114539152-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0168bfdc0675a5cfb9cb1e71662a289
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02W30-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D2009-0086
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D9-0045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-10
filingDate 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d17c622d2b388a29b374f0855e9b6b
publicationDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114539152-A
titleOfInvention Crystallization device and crystallization method of ε-caprolactam crude product
abstract A crystallization device and a crystallization method of an ε-caprolactam crude product. The method includes the processes of crystallization, water extraction, hydrogenation, evaporation and dehydration, does not require solid-liquid separation, can produce high-quality ε-caprolactam products, and is especially suitable for the purification of crude ε-caprolactam obtained by gas-phase rearrangement. The caprolactam purification device provided by the invention comprises a crystallizer, a countercurrent scrubber, a phase separator, a hydrogenation reactor and a distillation device which are connected in sequence; the structure is simple, the continuous operation is possible, and it is suitable for the purification process of crude caprolactam.
priorityDate 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141368347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465722456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22222215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415756202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449360014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423008554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512365

Total number of triples: 35.